Cargando…

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer

Hypoxia—a common feature of the majority of solid tumors—is a negative prognostic factor, as it is associated with invasion, metastasis and therapy resistance. To date, a variety of methods are available for the assessment of tumor hypoxia, including the use of positron emission tomography (PET). A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanduleanu, Sebastian, van der Wiel, Alexander M.A., Lieverse, Relinde I.Y., Marcus, Damiënne, Ibrahim, Abdalla, Primakov, Sergey, Wu, Guangyao, Theys, Jan, Yaromina, Ala, Dubois, Ludwig J., Lambin, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280995/ https://www.ncbi.nlm.nih.gov/pubmed/32455922 http://dx.doi.org/10.3390/cancers12051322

Ejemplares similares

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
por: Olivo Pimentel, Veronica, et al.
Publicado: (2021)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
por: Marcus, Damiënne, et al.
Publicado: (2021)

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer
por: Verwer, E. E., et al.
Publicado: (2016)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape
por: Hamis, Sara, et al.
Publicado: (2020)

Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
por: van der Wiel, Alexander M. A., et al.
Publicado: (2022)

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
por: van der Wiel, Alexander M.A., et al.
Publicado: (2021)

Deep learning in fracture detection: a narrative review
por: Kalmet, Pishtiwan H S, et al.
Publicado: (2020)

Deep learning in fracture detection: a narrative review
por: Kalmet, Pishtiwan H S, et al.
Publicado: (2020)

[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis
por: Moreno Roig, Eloy, et al.
Publicado: (2018)

Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

Polyphenols as Potential Protectors against Radiation-Induced Adverse Effects in Patients with Thoracic Cancer
por: Prades-Sagarra, Èlia, et al.
Publicado: (2023)

Breaking the HxNy outbreak
por: Manikandan, Jayapal, et al.
Publicado: (2010)

Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells
por: Kazokaitė, Justina, et al.
Publicado: (2018)

Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
por: Zegers, Catharina M. L., et al.
Publicado: (2015)

Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
por: Zegers, Catharina M. L., et al.
Publicado: (2016)

Structural and functional radiomics for lung cancer
por: Wu, Guangyao, et al.
Publicado: (2021)

Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
por: Sosa Iglesias, Venus, et al.
Publicado: (2018)

In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activity
por: Panth, Kranthi Marella, et al.
Publicado: (2016)

Thermal Properties of Bayfol(®) HX200 Photopolymer
por: Blanche, Pierre-Alexandre, et al.
Publicado: (2020)

Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy
por: Kubiak, Aleksandra M., et al.
Publicado: (2021)

Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide
por: Mowday, Alexandra M., et al.
Publicado: (2020)

The Chemistry and Physics of Bayfol(®) HX Film Holographic Photopolymer
por: Bruder, Friedrich-Karl, et al.
Publicado: (2017)

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer
por: Maduell, Francisco, et al.
Publicado: (2023)

One health insights to prevent the next HxNy viral outbreak: learning from the epidemiology of H7N9
por: Zheng, Zhe, et al.
Publicado: (2019)

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [(18)F]HX4 PET imaging study in colorectal cancer xenografts
por: De Bruycker, Sven, et al.
Publicado: (2019)

Hypoxia imaging with [(18)F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning
por: Betts, Helen M., et al.
Publicado: (2019)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
por: Rekers, Nicolle H., et al.
Publicado: (2018)

Analysis of relative displacement between the HX wearable robotic exoskeleton and the user’s hand
por: Cempini, Marco, et al.
Publicado: (2014)

Electrochemical Oxidative Clean Halogenation Using HX/NaX with Hydrogen Evolution
por: Yuan, Yong, et al.
Publicado: (2019)

Basic features of Ne*–HX (X = Cl, Br) chemi-ionization reactions
por: Falcinelli, Stefano, et al.
Publicado: (2022)

The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy
por: van Kuijk, Simon J. A., et al.
Publicado: (2016)

Botanical preparation HX109 inhibits macrophage-mediated activation of prostate epithelial cells through the CCL4-STAT3 pathway: implication for the mechanism underlying HX109 suppression of prostate hyperplasia
por: Lim, Seonung, et al.
Publicado: (2020)

HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience
por: Dellanna, Frank, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ptab9qf5rsljju7es9i34l0d2c